scispace - formally typeset
M

Mei Hong

Researcher at Massachusetts Institute of Technology

Publications -  256
Citations -  14654

Mei Hong is an academic researcher from Massachusetts Institute of Technology. The author has contributed to research in topics: Lipid bilayer & Nuclear magnetic resonance spectroscopy. The author has an hindex of 64, co-authored 240 publications receiving 12628 citations. Previous affiliations of Mei Hong include University of Massachusetts Amherst & University of California, Los Angeles.

Papers
More filters
Journal ArticleDOI

Structure of the amantadine binding site of influenza M2 proton channels in lipid bilayers

TL;DR: Solid-state NMR spectroscopy indicates that amantadine physically occludes the M2 channel, thus paving the way for developing new antiviral drugs against influenza viruses and demonstrates the ability of solid- state NMR to elucidate small-molecule interactions with membrane proteins and determine high-resolution structures of their complexes.
Journal ArticleDOI

Structure and interactions of plant cell-wall polysaccharides by two- and three-dimensional magic-angle-spinning solid-state NMR.

TL;DR: The results suggest that load bearing in plant CWs is accomplished by a single network of all three types of polysaccharides instead of a cellulose-xyloglucan network, thus revising the existing paradigm of CW structure.
Journal ArticleDOI

Mechanisms of Proton Conduction and Gating in Influenza M2 Proton Channels from Solid-State NMR

TL;DR: Solid-state nuclear magnetic resonance spectroscopy was used to determine the structure and functional dynamics of the pH-sensing and proton-selective histidine-37 in M2 bound to a cholesterol-containing virus-envelope-mimetic membrane so as to better understand the proton conduction mechanism.
Journal ArticleDOI

De novo design of a transmembrane Zn2+-transporting four-helix bundle.

TL;DR: A membrane-spanning, four-helical bundle that transports first-row transition metal ions Zn2+ and Co2+, but not Ca2+, across membranes is reported, which illustrates the feasibility of designing membrane proteins with predefined structural and dynamic properties.
Journal ArticleDOI

Structure and drug binding of the SARS-CoV-2 envelope protein transmembrane domain in lipid bilayers.

TL;DR: The structure and the drug-binding site of E’s transmembrane domain (ETM), determined using solid-state NMR spectroscopy, sets the stage for designing E inhibitors as antiviral drugs.